Page last updated: 2024-10-23

azathioprine and Amyloid Neuropathy Type 1

azathioprine has been researched along with Amyloid Neuropathy Type 1 in 1 studies

Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lobato, L1
Ventura, A1
Beirão, I1
Miranda, HP1
Seca, R1
Henriques, AC1
Teixeira, M1
Sarmento, AM1
Pereira, MC1

Other Studies

1 other study available for azathioprine and Amyloid Neuropathy Type 1

ArticleYear
End-stage renal disease in familial amyloidosis ATTR Val30Met: a definitive indication to combined liver-kidney transplantation.
    Transplantation proceedings, 2003, Volume: 35, Issue:3

    Topics: Amino Acid Substitution; Amyloid Neuropathies, Familial; Antibiotic Prophylaxis; Antilymphocyte Seru

2003